Why is My Patient Anemic?

Hematology/Oncology Clinics of North America

Volumn 26, Issue 2, 2012, Pages 205-230

  Bryan, Locke J ^a   Zakai, Neil A ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b University of Vermont Colchester Research Facility   (United States)

Author keywords

Anemia; Blood cell count; Clinical medicine; Review

Indexed keywords

ALCOHOL; ALKYLATING AGENT; AMINOMETHYLTRANSFERASE; ANTHRACYCLINE; ANTIANDROGEN; ANTICONVULSIVE AGENT; ANTIMETABOLITE; BENZENE; CHLORAMPHENICOL; COBALAMIN; COLCHICINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FOLIC ACID; HEMOGLOBIN; HEXOKINASE 1; HYDROXYUREA; LEAD; MEMBRANE PROTEIN; METFORMIN; METHOTREXATE; METHYLDOPA; PENICILLIN G; PROTEIN KINASE C; PROTON PUMP INHIBITOR; QUINIDINE; SULFONAMIDE; UNINDEXED DRUG; ZIDOVUDINE; ZINC;

ACUTE LEUKEMIA; AGE; ANEMIA; ANGIOMA; ASCITES; AUTOIMMUNE HEMOLYTIC ANEMIA; AVIAN TUBERCULOSIS; BABESIA DIVERGENS; BABESIA MICROTI; BLOOD SMEAR; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; CHRONIC KIDNEY DISEASE; CHRONIC LEUKEMIA; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS INFECTION; CYANOCOBALAMIN DEFICIENCY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ERYTHEMA INFECTIOSUM; ERYTHROCYTE; ERYTHROPOIESIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FOLIC ACID DEFICIENCY; HEART FAILURE; HEART INFARCTION; HEAVY METAL POISONING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMEGALY; HEREDITY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; HYPERTENSION; HYPOGONADISM; HYPOTHYROIDISM; IRON DEFICIENCY ANEMIA; JAUNDICE; MALARIA FALCIPARUM; MEDICAL HISTORY; MULTIPLE MYELOMA; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; MYELODYSPLASTIC SYNDROME; NONHUMAN; NORMOCHROMIC NORMOCYTIC ANEMIA; OSTEOMYELITIS; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM MALARIAE INFECTION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SICKLE CELL ANEMIA; STREPTOCOCCUS PNEUMONIAE; STROKE; THALASSEMIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUBERCULOSIS;

ANEMIA; ERYTHROCYTE INDICES; ERYTHROPOIESIS; HUMANS; INFECTION; INFLAMMATION; PHARMACEUTICAL PREPARATIONS;

EID: 84859095734     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.02.008     Document Type: Review

References (65)

1. Lichtman MA, Beutler E, Kipps TJ, et al, editors. Williams hematology. 7th edition. New York (NY): The McGraw-Hill Companies, Inc.; 2006.
2. Nissenson A.R., Goodnough L.T., Dubois R.W. Anemia: not just an innocent bystander?. Arch Intern Med 2003, 163(12):1400-1404.
3. Zakai N.A., Katz R., Hirsch C., et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005, 165(19):2214-2220.
4. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968, 405:5-37.
5. Beutler E., Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood 2006, 107(5):1747-1750.
6. Ganesh S.K., Zakai N.A., van Rooij F.J., et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009, 41(11):1191-1198.
7. den Elzen W.P., Gussekloo J. Anaemia in older persons. Neth J Med 2011, 69(6):260-267.
8. Kuk J.L., Saunders T.J., Davidson L.E., et al. Age-related changes in total and regional fat distribution. Ageing Res Rev 2009, 8(4):339-348.
9. Zakai N.A., McClure L.A., Prineas R., et al. Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol 2009, 169(3):355-364.
10. Culleton B.F., Manns B.J., Zhang J., et al. Impact of anemia on hospitalization and mortality in older adults. Blood 2006, 107(10):3841-3846.
11. Zakai N.A., French B., Arnold A., et al. Hemoglobin decline and health outcomes in the elderly: the cardiovascular health study. ASH Annual Meeting Abstracts 2008, 112(11):3448.
12. Beutler E., West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005, 106(2):740-745.
13. Dill D.B., Terman J.W., Hall F.G. Hemoglobin at high altitude as related to age. Clin Chem 1963, 12:710-716.
14. Beall C.M., Brittenham G.M., Strohl K.P., et al. Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 1998, 106(3):385-400.
15. Shahidi N.T. Androgens and erythropoiesis. N Engl J Med 1973, 289(2):72-80.
16. Ferrucci L., Maggio M., Bandinelli S., et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006, 166(13):1380-1388.
17. Curtis K.K., Adam T.J., Chen S.C., et al. Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart review. Aging Male 2008, 11(4):157-161.
18. Pratt M.C., Lewis-Barned N.J., Walker R.J., et al. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 1992, 34(4):363-365.
19. Adamson J., Longo D. Anemia and Polycythemia. Harrison's Principles of Internal Medicine 2008, 337. McGraw-Hill, New York, Chapter 57. 17th edition. A. Fauci, E. Braunwald, D. Kasper (Eds.).
20. Hallberg L., Hulthén L., Bengtsson C., et al. Iron balance in menstruating women. Eur J Clin Nutr 1995, 49(3):200-207.
21. Bermejo B., Olona M., Serra M., et al. Rev Clin Esp 1996, 196(7):446-450. [in Spanish].
22. Yun E.J., Meng M.V., Carroll P.R. Evaluation of the patient with hematuria. Med Clin North Am 2004, 88(2):329-343.
23. González C., Penado S., Llata L., et al. The clinical spectrum of retroperitoneal hematoma in anticoagulated patients. Medicine (Baltimore) 2003, 82(4):257-262.
24. Skikne B., Lynch S., Borek D., et al. Iron and blood donation. Clin Haematol 1984, 13(1):271-287.
25. Salisbury A.C., Reid K.J., Alexander K.P., et al. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. Arch Intern Med 2011, 171(18):1646-1653.
26. Zahner J., Schneider W. Munchausen syndrome in hematology: case reports of three variants and review of the literature. Ann Hematol 1994, 68(6):303-306.
27. Lechner K., Jager U. How I treat autoimmune hemolytic anemias in adults. Blood 2010, 116(11):1831-1838.
28. Mecozzi G., Milano A.D., Carlo M.D., et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg 2002, 123(3):550-556.
29. Burns E.R., Lou Y., Pathak A. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol 2004, 75(1):18-21.
30. George J.N. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010, 116(20):4060-4069.
31. White N.J. The treatment of malaria. N Engl J Med 1996, 335(11):800-806.
32. Hatcher J.C., Greenberg P.D., Antique J., et al. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001, 32(8):1117-1125.
33. Crowther M., Chan Y.L.T., Garbett I.K., et al. Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood 2011, 118(15):4036-4040.
34. Toxicological profile for lead 2007, US Department of Health & Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta (GA), Available at:, Accessed November 01, 2011. http://www.atsdr.cdc.gov/toxprofiles/tp.asp%3Fid=96&tid=22.
35. Stoltzfus R. Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr 2001, 131(2S-2):565S-567S.
36. Cook J.D. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005, 18(2):319-332.
37. Das K.C., Mukherjee M., Sarkar T.K., et al. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 1975, 40(2):211-220.
38. Colon-Otero G., Menke D., Hook C.C. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am 1992, 76(3):581-597.
39. Qamar A.A., Grace N.D. Abnormal hematological indices in cirrhosis. Can J Gastroenterol 2009, 23(6):441-445.
40. Humphries J.E. Anemia of renal failure. Use of erythropoietin. Med Clin North Am 1992, 76(3):711-725.
41. Peralta C.A., Shlipak M.G., Judd S., et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011, 305(15):1545-1552.
42. Astor B.C., Muntner P., Levin A., et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002, 162(12):1401-1408.
43. Ble A., Fink J.C., Woodman R.C., et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med 2005, 165(19):2222-2227.
44. Kosiborod M., Curtis J.P., Wang Y., et al. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 2005, 165(19):2237-2244.
45. Fisch P., Handgretinger R., Schaefer H.E. Pure red cell aplasia. Br J Haematol 2000, 111(4):1010-1022.
46. Young N.S. Acquired aplastic anemia. Ann Intern Med 2002, 136(7):534-546.
47. Bacigalupo A., Passweg J. Diagnosis and treatment of acquired aplastic anemia. Hematol Oncol Clin North Am 2009, 23(2):159-170.
48. Makoni S.N., Laber D.A. Clinical spectrum of myelophthisis in cancer patients. Am J Hematol 2004, 76(1):92-93.
49. Volberding P.A., Baker K.R., Levine A.M. Human immunodeficiency virus hematology. Hematology Am Soc Hematol Educ Program 2003, 294-313. Available at:, Accessed February 21, 2012. http://asheducationbook.hematologylibrary.org/content/2003/1.toc.
50. Browne P.M., Sharma O.P., Salkin D. Bone marrow sarcoidosis. JAMA 1978, 240(24):2654-2655.
51. Licci S. Extensive bone marrow amyloidosis. Ann Hematol 2011.
52. Leguit R.J., van den Tweel J.G. The pathology of bone marrow failure. Histopathology 2010, 57(5):655-670.
53. Semba R.D., Martin B.K., Kempen J.H., et al. The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005, 165(19):2229-2236.
54. Hourihane D.O., Weir D.G. Suppression of erythropoiesis by alcohol. Br Med J 1970, 1(5688):86-89.
55. Kaferle J., Strzoda C.E. Evaluation of macrocytosis. Am Fam Physician 2009, 79(3):203-208.
56. Patel K.V. Epidemiology of anemia in older adults. Semin Hematol 2008, 45(4):210-217.
57. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352(10):1011-1023.
58. Zarychanski R., Houston D.S. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?. CMAJ 2008, 179(4):333-337.
59. Wang C.Q., Udupa K.B., Lipschitz D.A. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol 1995, 162(1):134-138.
60. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998, 18(8):555-559.
61. Sears D.A. Anemia of chronic disease. Med Clin North Am 1992, 76(3):567-579.
62. Kratz A., Ferraro M., Sluss P.M., et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 2004, 351(15):1548-1563.
63. Kueviakoe I., Segbena A.Y., Jouault H., et al. Hematological reference values for health adults in Togo. ISRN Hematol 2011, 2011:1-5.
64. Saathoff E., Schneider P., Kleinfeldt V., et al. Laboratory reference values for healthy adults from southern Tanzania. Trop Med Int Health 2008, 13(5):612-625.
65. Tsegaye A., Messele T., Tilahun T., et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999, 6(3):410-414.